UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) November 14, 2006
Health Care REIT, Inc.
(Exact name of registrant as specified in its charter)
| |
|
|
|
|
| Delaware
|
|
1-8923
|
|
34-1096634 |
| (State or other jurisdiction
|
|
(Commission
|
|
(IRS Employer |
| of incorporation)
|
|
File Number)
|
|
Identification No.) |
| |
|
|
| One SeaGate, Suite 1500, Toledo, Ohio
|
|
43604 |
| (Address of principal executive offices)
|
|
(Zip Code) |
Registrant’s telephone number, including area code (419) 247-2800
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item 2.03
Creation of a Direct Financial Obligation or an Obligation
under an Off-Balance Sheet Arrangement of a Registrant.
On November 14, 2006, pursuant to an automatic shelf registration statement on Form S-3 (File No.
333-134082) filed with the Securities and Exchange Commission on May 12, 2006, Health Care REIT
Inc. (the “Company”) entered into an Underwriting Agreement with UBS Securities LLC and Deutsche
Bank Securities Inc., as representatives of the several underwriters, for an offering of $300
million aggregate principal amount of 4.75% convertible senior notes due 2026 (the “Notes”). The
Notes were issued under an Indenture between the Company and The Bank of New York Trust Company,
N.A., as trustee (the “Trustee”), as supplemented by Supplemental Indenture No. 1 between the
Company and the Trustee.
The Notes pay interest semi-annually at a rate of 4.75% per year and mature on December 1, 2026.
The Notes are convertible, in certain circumstances, into cash and, if applicable, shares of the
Company’s common stock at an initial conversion rate of 20.8833 shares per $1,000 principal amount
of Notes, which represents an initial conversion price of approximately $47.89 per share. In
general, upon conversion, the holder of each Note would receive, in respect of the conversion value
of such Note, cash up to the principal amount of such Note and the Company’s common stock for the
Note’s conversion value in excess of such principal amount.
The Notes are senior unsecured obligations of the Company and are effectively subordinated to all
of the Company’s existing and future secured indebtedness and all existing and future liabilities
of the Company’s subsidiaries.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
| 1.1 |
|
Underwriting Agreement, dated as of November 14, 2006, between the Company and UBS Securities
LLC and Deutsche Bank Securities Inc., as representatives of the several underwriters. |
| |
| 4.1 |
|
Indenture, dated as of November 20, 2006, between the Company and the Trustee. |
| |
| 4.2 |
|
Supplemental Indenture No. 1, dated as of November 20, 2006, between the Company and the Trustee. |
| |
| 5 |
|
Opinion of Shumaker, Loop & Kendrick, LLP. |
| |
| 8 |
|
Tax Opinion of Arnold & Porter LLP. |
| |
| 23 |
|
Consent of Shumaker, Loop & Kendrick, LLP to the use of their opinion as an exhibit to this
Form 8-K is included in their opinion filed herewith as Exhibit 5. |
| |
| 25.1 |
|
Statement of Eligibility of the Trustee. |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant had
duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.
| |
|
|
|
|
|
|
| |
|
HEALTH CARE REIT, INC. |
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ GEORGE L. CHAPMAN
|
|
|
| |
|
George L. Chapman |
|
|
| |
|
Its: Chairman of the Board and
|
|
|
| |
|
Chief Executive Officer |
|
|
Dated: November 20, 2006